Company
-
26/05/04
2026/05/04
管理员
Aniview Support Tumor Theranostics Research: A ternary heterostructured nanocrystal featuring an S-scheme heterojunction for enhanced penetration and ROS-amplified tumor ablation
New progress has been made in multifunctional nanocatalytic tumor theranostics.
Learn More -
26/05/04
2026/05/04
管理员
PlantView Support Poplar Rust Resistance Research: Regulation of poplar rust resistance through the interaction between transcription factor PsERF117 and PR10.18
New progress has been made in the molecular regulatory mechanisms of poplar resistance to rust fungi.
Learn More -
26/04/28
2026/04/28
管理员
Aniview Support Skin Wound Healing and Regenerative Medicine : A Fibrous Scaffold Loaded with BMSC-Derived Apoptotic Bodies Promotes Wound Healing via Inducing Macrophage Polarization
New progress has been made in skin wound repair and regenerative medicine, particularly through the regulation of macrophage polarization.
Learn More -
26/04/28
2026/04/28
管理员
Aniview Support Cancer Immunotherapy Research: Identification of ADAM12 as a Fibroblast Checkpoint via Single-Cell Screening
New progress has been made in identifying novel targets for cancer immunotherapy through single-cell screening.
Learn More -
26/04/20
2026/04/20
管理员
Aniview Support Tumor Immunotherapy Research: An Epigenetic Nano-Agonist Promotes T Cell Priming, Recruitment, and Reactivation in PD-L1–Resistant Tumors
New progress has been made in the field of immunotherapy for PD-L1–resistant tumors.
Learn More -
26/04/20
2026/04/20
管理员
Aniview Support Tumor Immunotherapy Research: Antibody-Mediated Chemical Engineering of γδ T Cells Targeting Cancer Cells for Enhanced Tumor Immunotherapy
This study provides new insights into antibody-mediated chemical engineering of γδ T cells for enhancing tumor-targeting capability and improving antitumor immune responses.
Learn More -
26/01/05
2026/01/05
管理员
BLT Secures Orders from Multiple Countries, AniView Series In Vivo Imaging Systems Demonstrate International Competitiveness
Recently, Guangzhou Biolight Biotechnology Co., Ltd. (hereinafter referred to as “BLT”) announced that its core product, the AniView series of live imaging systems, has secured a series of significant orders in overseas markets.
Learn More -
25/11/16
2025/11/16
管理员
BLT and UCLA Crump Institute Establish First Joint In Vivo Imaging Demonstration Center in North America
On 2025 November 7, the UCLA Crump Institute for Molecular Imaging (CIMI-UCLA) and Guangzhou Biolight Technology Co., Ltd. (BLT) jointly announced the establishment of the CIMI-UCLA & BLT In Vivo Imaging Center at the University of California, Los Angeles.
Learn More